Overview

A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

Status:
NOT_YET_RECRUITING

Trial end date:
2028-02-10

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess how well JNJ-95597528 works compared to placebo in participants with moderate to severe atopic dermatitis (AD).

Phase:

PHASE2

Details

Lead Sponsor:

Janssen Research & Development, LLC